View Older Stories

Apr 29, 2026 07:00AM Oruka Therapeutics (ORKA) PT Raised to $120 at H.C. Wainwright

Apr 27, 2026 04:12PM Oruka Therapeutics (ORKA) PT Raised to $131 at Clear Street

Apr 27, 2026 12:19PM Oruka Therapeutics (ORKA) PT Raised to $160 at Barclays

Apr 27, 2026 11:24AM Oruka Therapeutics (ORKA) PT Raised to $200 at Guggenheim

Apr 27, 2026 10:10AM Oruka Therapeutics (ORKA) PT Raised to $165 at Wedbush

Apr 27, 2026 10:06AM Oruka Therapeutics (ORKA) PT Raised to $151 at BTIG

Apr 27, 2026 09:36AM Oruka Therapeutics (ORKA) PT Raised to $150 at Stifel

Apr 27, 2026 07:17AM Stifel on Oruka Therapeutics (ORKA): 'We expect shares to trade meaningfully-higher'

Apr 20, 2026 08:51AM TD Cowen on Oruka Therapeutics (ORKA): '39-49% Or Higher PASI 100 Should Unlock Multi-Billion Sales'

Apr 15, 2026 07:19AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Apr 13, 2026 06:40AM Oruka Therapeutics (ORKA) PT Raised to $70 at H.C. Wainwright

Apr 13, 2026 05:51AM Oruka Therapeutics (ORKA) PT Raised to $78 at BTIG

Apr 8, 2026 04:42PM Stifel stays Buy on Oruka Therapeutics (ORKA) after Ph2a data from EVERLAST-A study

Apr 6, 2026 09:27AM UBS Reiterates Buy Rating on Oruka Therapeutics (ORKA) Following Data Readout

Apr 6, 2026 06:42AM Oruka Therapeutics (ORKA) PT Raised to $125 at Guggenheim

Apr 2, 2026 04:11PM Oruka Therapeutics (ORKA) files $1B mixed shelf

Mar 26, 2026 06:23AM Oruka Therapeutics (ORKA) PT Raised to $109 at Leerink Partners

Mar 24, 2026 08:56AM Piper Sandler on Oruka Therapeutics (ORKA): 'Now Is the Time to Own the Name'

Mar 13, 2026 09:26AM BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA): 'Commercial Precedents Continue to Read Through Positively to ORKA-001/2'

Mar 12, 2026 05:53PM Oruka Therapeutics (ORKA) PT Raised to $72 at Stifel

Mar 12, 2026 05:19PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 45c

Jan 13, 2026 05:09AM Oruka Therapeutics (ORKA) PT Raised to $71 at Clear Street

Jan 7, 2026 12:50AM UBS Starts Oruka Therapeutics (ORKA) at Buy

Dec 18, 2025 04:02AM Piper Sandler Starts Oruka Therapeutics (ORKA) at Overweight

Dec 11, 2025 04:01PM Oruka Therapeutics adds Chris Martin to board, Cameron Turtle resigns

Nov 13, 2025 06:32AM Oruka Therapeutics (ORKA) Misses Q3 EPS by 55c

Nov 13, 2025 04:29AM Oruka Therapeutics (ORKA) PT Raised to $63 at BTIG

Nov 13, 2025 04:03AM Jefferies Starts Oruka Therapeutics (ORKA) at Buy

Oct 27, 2025 06:49AM Oruka Therapeutics (ORKA) PT Lowered to $40 at H.C. Wainwright

Oct 27, 2025 06:13AM Guggenheim Starts Oruka Therapeutics (ORKA) at Buy

Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files for 39.43M share offering by selling stockholders

Oct 14, 2025 04:48PM Oruka Therapeutics (ORKA) files $500M mixed shelf

Oct 13, 2025 05:31AM Barclays Starts Oruka Therapeutics (ORKA) at Overweight

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 17, 2025 03:37PM Oruka Therapeutics (ORKA) PT Raised to $56 at BTIG

Aug 20, 2025 04:33PM Clear Street Starts Oruka Therapeutics (ORKA) at Buy

Aug 12, 2025 05:04AM BTIG Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Aug 11, 2025 04:48PM Oruka Therapeutics (ORKA) Misses Q2 EPS by 46c

Jul 23, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Jul 21, 2025 08:03AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Jul 1, 2025 04:01PM Oruka Therapeutics (ORKA) Appoints Laura Sandler as COO

May 27, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

May 22, 2025 06:07AM BTIG Starts Oruka Therapeutics (ORKA) at Buy

May 20, 2025 04:01PM Oruka Therapeutics (ORKA) Announces First Participants Dosed in Phase 1 Trial of ORKA-002, its Novel Half-life Extended Anti-IL-17A/F Antibody

May 14, 2025 06:28PM Oruka Therapeutics (ORKA) Misses Q1 EPS by 40c

Mar 7, 2025 07:41AM Stifel Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Mar 6, 2025 05:18PM Oruka Therapeutics (ORKA) Misses Q4 EPS by 49c

Dec 20, 2024 06:52AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

Nov 25, 2024 06:45AM H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)

View Older Stories